Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

Despite major advances in first-line treatment, a significant proportion of patients with diffuse large B-cell lymphoma (DLBCL) will experience treatment failure. Prognosis is particularly poor for relapses occurring less than one year after the end of first-line treatment (early relapses/ER) compar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Broséus, Julien, Chen, Gaili, Hergalant, Sébastien, Ramstein, Gérard, Mounier, Nicolas, Guéant, Jean-Louis, Feugier, Pierre, Gisselbrecht, Christian, Thieblemont, Catherine, Houlgatte, Rémi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356640/
https://ncbi.nlm.nih.gov/pubmed/27276707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados